> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# SI-Bone iFuse Bedrock Gains Expanded Clearance
- URL: https://www.fdaweb.com/si-bone-ifuse-bedrock-gains-expanded-clearance/
- Published: 2019-04-16T12:00:00.000Z
- Updated: 2026-09-15T01:20:34.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5143879

FDA has cleared a SI-Bone 510(k) for use of its iFuse Bedrock technology in fusion of the sacroiliac (SI) joint during long construct procedures. The company says that iFuse Bedrock is a technology designed to provide greater joint stabilization at the base of long spinal constructs. The device was previously cleared for sacroiliac fusion using a dorsal, or posterior, implantation approach to treat sacroiliac joint dysfunction in patients also undergoing long fusion procedures involving a posterior approach. “With this new broader indication, iFuse Bedrock can now be placed across the SI joint as an adjunct to long fusion procedures with the intent of gaining fusion to augment immobilization and stabilization of the SI joint,” the company says.